| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Aligos Therapeutics (NASDAQ:ALGS) reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Aligos Therapeutics beat estimated earnings by 19.0%, reporting an EPS of $-0.22 versus an estimate of $-0.27.
Revenue was down $1.53 million from the same period last year.
Last quarter the company beat on EPS by $0.06 which was followed by a 1.0% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Aligos Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ALGS
